Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype

Uveal melanomas possess activation of the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT/mammalian Target of Rapamycin (mTOR) pathways. MAPK activation occurs via somatic mutations in the heterotrimeric G protein subunits GNAQ and GNA11 for over 70% of tumors and le...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Alan L., Musi, Elgilda, Ambrosini, Grazia, Nair, Jayasree S., Deraje Vasudeva, Shyamprasad, de Stanchina, Elisa, Schwartz, Gary K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393714/
https://www.ncbi.nlm.nih.gov/pubmed/22808163
http://dx.doi.org/10.1371/journal.pone.0040439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393714/
https://www.ncbi.nlm.nih.gov/pubmed/22808163
http://dx.doi.org/10.1371/journal.pone.0040439

Ejemplares similares